PL2700411T3 - Probiotyki, wydzielnicze IgA a zakażenie - Google Patents

Probiotyki, wydzielnicze IgA a zakażenie

Info

Publication number
PL2700411T3
PL2700411T3 PL13188128T PL13188128T PL2700411T3 PL 2700411 T3 PL2700411 T3 PL 2700411T3 PL 13188128 T PL13188128 T PL 13188128T PL 13188128 T PL13188128 T PL 13188128T PL 2700411 T3 PL2700411 T3 PL 2700411T3
Authority
PL
Poland
Prior art keywords
probiotics
infection
secretory iga
secretory
iga
Prior art date
Application number
PL13188128T
Other languages
English (en)
Inventor
Jalil Benyacoub
Blaise Corthesy
Stéphanie Blum-Sperisen
Laurent Favre
Original Assignee
Nestec S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39832407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2700411(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec S.A. filed Critical Nestec S.A.
Publication of PL2700411T3 publication Critical patent/PL2700411T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Pediatric Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL13188128T 2008-06-24 2009-06-16 Probiotyki, wydzielnicze IgA a zakażenie PL2700411T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08158833A EP2138187A1 (en) 2008-06-24 2008-06-24 Probiotics, secretory IgA and infection
EP13188128.6A EP2700411B1 (en) 2008-06-24 2009-06-16 Probiotics, secretory IgA and infection

Publications (1)

Publication Number Publication Date
PL2700411T3 true PL2700411T3 (pl) 2017-06-30

Family

ID=39832407

Family Applications (2)

Application Number Title Priority Date Filing Date
PL13188128T PL2700411T3 (pl) 2008-06-24 2009-06-16 Probiotyki, wydzielnicze IgA a zakażenie
PL09769156T PL2318047T3 (pl) 2008-06-24 2009-06-16 Probiotyki, wydzielnicze iga a zakażenie

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL09769156T PL2318047T3 (pl) 2008-06-24 2009-06-16 Probiotyki, wydzielnicze iga a zakażenie

Country Status (11)

Country Link
US (3) US9173937B2 (pl)
EP (3) EP2138187A1 (pl)
JP (1) JP2011525484A (pl)
CN (2) CN102076361A (pl)
AU (1) AU2009264423B2 (pl)
BR (1) BRPI0914624B1 (pl)
CA (1) CA2727303A1 (pl)
ES (2) ES2616334T3 (pl)
PL (2) PL2700411T3 (pl)
PT (2) PT2318047E (pl)
WO (1) WO2009156307A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2138186A1 (en) * 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and inflammation
JP2012180304A (ja) * 2011-03-01 2012-09-20 Biseibutsu Kagaku Kenkyusho:Kk 鶏のカンピロバクター感染を制御するための飲料
PT2734049T (pt) 2011-06-20 2018-07-24 Heinz Co Brands H J Llc Composições e métodos probióticos
MX363899B (es) 2012-06-18 2019-04-05 Heinz Co Brands H J Llc Trastornos relacionados con gluten.
US9458230B2 (en) * 2013-01-04 2016-10-04 Wisconsin Alumni Research Foundation Secretory IGA compositions, methods of making and methods of use thereof
BR112015028164B1 (pt) 2013-05-10 2022-02-08 H.J. Heinz Company Brands Llc Usos da bactéria probiótica, lactobacillus paracasei, para tratar uma infecção microbiana e para prevenir ou reduzir a gravidade de uma infecção microbiana
US9468674B2 (en) 2013-09-24 2016-10-18 Wisconsin Alumni Research Foundation Methods of use of secretory IgA
EP3011966A1 (en) * 2014-08-08 2016-04-27 Institut National De La Recherche Agronomique Compositions for the inhibition of Giardia Lamblia
CN104473292A (zh) * 2014-12-22 2015-04-01 威海百合生物技术股份有限公司 一种婴幼儿益生菌固体饮料
WO2018220416A1 (en) * 2017-05-31 2018-12-06 Compagnie Gervais Danone Lactobacillus paracasei strain capable of improving the immune response to a viral-bacterial coinfection
TWI731209B (zh) * 2018-01-09 2021-06-21 柯順議 益生菌組合物及其用途
JP2022529054A (ja) * 2019-04-17 2022-06-16 ニューテック・ベンチャーズ 持続性が強化された新規微生物を含む組成物、新規微生物とプレバイオティクスの相乗的組み合わせ、およびそのような微生物の分離方法
PH12021552934A1 (en) 2019-06-28 2022-07-25 Nestle Sa COMPOSITIONS COMPRISING SECRETORY IgA AND PROBIOTICS
WO2021021746A1 (en) * 2019-07-26 2021-02-04 Evolve Biosystems, Inc. NUTRITIVE COMPOSITIONS WITH SECRETED IgA, MILK FAT GLOBULE MEMBRANE COMPONENTS AND/OR BIFIDOBACTERIUM
EP4034145A4 (en) * 2019-09-24 2023-10-11 The Regents of the University of California BENEFICIAL BACTERIA AND SECRETORY IMMUNOGLOBULIN
WO2021219786A1 (en) 2020-04-30 2021-11-04 Gottfried Himmler Anti-toxin secretory iga2 preparation
TWI823060B (zh) * 2021-02-26 2023-11-21 豐華生物科技股份有限公司 提升口腔免疫球蛋白a含量及抑制口腔病原菌之組成物及其用途
EP4451918B1 (en) * 2021-12-20 2026-02-25 Société des Produits Nestlé S.A. Secretory iga-biotic complexes and uses thereof
CN118995516B (zh) * 2024-09-03 2025-09-23 江南大学 一株具有提高宿主分泌型免疫球蛋白表达增强其抗感染的唾液联合乳杆菌及其后生元

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5589233A (en) * 1978-12-28 1980-07-05 Shogo Nakano Preparation of additive for breeding of new born cattle
JP2968374B2 (ja) * 1991-05-16 1999-10-25 株式会社ヤクルト本社 IgA産生促進剤
JPH06234647A (ja) * 1993-02-12 1994-08-23 Yakult Honsha Co Ltd IgA産生促進剤およびその製造法
JP3269890B2 (ja) * 1993-08-25 2002-04-02 株式会社ヤクルト本社 ワクチンの効果増強剤及び効果増強食品
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
AUPN698495A0 (en) * 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
EP0990001B1 (en) * 1997-05-29 2006-05-10 Agresearch Limited Processes for production of immunoglobulin a in milk
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
DE60231322D1 (de) * 2001-11-12 2009-04-09 Mars Inc Nahrungsmittel für katzen und hunde
KR101095712B1 (ko) * 2003-08-21 2011-12-20 오츠카 세이야쿠 가부시키가이샤 점막 면역 부활 작용을 갖는 유산균
CN101151041B (zh) * 2005-02-02 2012-12-05 株式会社明治 免疫刺激用组合物
TW200716664A (en) * 2005-05-10 2007-05-01 Murray Goulburn Coop Co Ltd Immunoglobulin fraction and process therefor
ZA200800978B (en) * 2005-08-19 2009-08-26 Unilever Plc Food products comprising probiotic micro-organisms and antibodies
US20080145420A1 (en) * 2006-12-13 2008-06-19 Simon Michael R HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES
EP2138186A1 (en) 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and inflammation
JP5589233B2 (ja) 2011-08-24 2014-09-17 株式会社 life park. biz 消火器の基台

Also Published As

Publication number Publication date
EP2700411A1 (en) 2014-02-26
US20160106834A1 (en) 2016-04-21
PT2318047E (pt) 2014-06-24
EP2318047B1 (en) 2014-05-14
PT2700411T (pt) 2017-03-29
CN102076361A (zh) 2011-05-25
EP2318047A1 (en) 2011-05-11
EP2138187A1 (en) 2009-12-30
CA2727303A1 (en) 2009-12-30
US20170281757A1 (en) 2017-10-05
AU2009264423B2 (en) 2014-01-16
US9173937B2 (en) 2015-11-03
EP2700411B1 (en) 2016-12-28
AU2009264423A1 (en) 2009-12-30
WO2009156307A1 (en) 2009-12-30
PL2318047T3 (pl) 2014-10-31
BRPI0914624B1 (pt) 2021-11-09
US20120014963A1 (en) 2012-01-19
ES2477882T3 (es) 2014-07-18
US9629908B2 (en) 2017-04-25
ES2616334T3 (es) 2017-06-12
ES2477882T5 (es) 2018-11-07
EP2318047B2 (en) 2018-08-15
CN105816875A (zh) 2016-08-03
BRPI0914624A2 (pt) 2015-10-20
JP2011525484A (ja) 2011-09-22

Similar Documents

Publication Publication Date Title
PL2318047T3 (pl) Probiotyki, wydzielnicze iga a zakażenie
PT2318046E (pt) Probióticos, iga secretora e inflamação
PL3729998T3 (pl) Złożony element zawierający dwa elementy panelowe
BRPI1010574A2 (pt) cereal infantil compreendendo micro-organismos probióticos não replicantes.
PL2354161T3 (pl) Przeciwciało anty -NR10 i jego zastosowanie
IL210804A (en) Benzylidenehydrazides and their uses
ZA201100261B (en) Anti-hepcidin-25 selective antibodies and uses thereof
AP2011006039A0 (en) Mobile self-contained stone-making and concrete-processing factory.
AP2010005166A0 (en) Vaccines
PL2247601T3 (pl) Tiazopirymidynony i ich zastosowanie
SI2354161T1 (sl) Anti-NR10 protitelo in njegova uporaba
AP2012006303A0 (en) Anti-trypanosomiasis vaccines and diagnostics.
EP2509708B8 (en) Silicon phosphate and membrane comprising the same
GB201013552D0 (en) Maximum entropy application methods and systems
GB0703763D0 (en) Bone-replacement materials,methods and devices
TWI346557B (en) Adjuvant and vaccine includes the same
TWI370824B (en) The phpit and fabrication thereof
EP2322806A4 (en) NOZZLE PRESSURE BLOWER
TWI349706B (en) Bacillus probiotics expression systems
GB0901707D0 (en) Assay products, devices and method
AU2009903328A0 (en) Building Element and System
HK1144231A (en) Vaccines
HK1166096A (en) Vangl1 peptides and vaccines including the same
HK1170747A (en) Tmem22 peptides and vaccines including the same
AU2008903893A0 (en) Up and outz